An Update on MET-201: Preclinical Progress in UTI & Indication Expansion Strategy Ahead
Time: 3:45 pm
day: Pre-Conference Focus Day
Details:
- MVT-201 is an orally administered capsule generated under cGMP conditions that represents the complete microbiota ecosystem
- New in vitro / in vivo data, leveraging infectious disease models, generating stability data
- Developing a strategy for whole ecosystem derived and consortia LBP therapeutic development for indications beyond infectious, based on market analysis and opportunities provided by novel platform development
